Daniel Rabinowitz - 01 Mar 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

SEC evidence 5 source fields
Form type
4
Accepted by SEC
01 Mar 2024, 20:45:31 UTC
Previous filing
29 Feb 2024
Next filing
07 Mar 2024
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ Tami Chen, Attorney-in-Fact

Key filing fact

Daniel Rabinowitz filed Form 4 for Natera, Inc. (NTRA) on 01 Mar 2024.

Key facts

  • This page summarizes Daniel Rabinowitz's Form 4 filing for Natera, Inc. (NTRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Mar 2024, 20:45.

Change

  • Previous filing in this sequence was filed on 29 Feb 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Award

Transaction value
Shares
+2,160
Change %
+1.1%
Price
Shares after
206,378
Date
01 Mar 2024
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.

Footnote F2

Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .